Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Christina Lake CannabisCLCFF -8.93% EV-to-EBIT is 1.95 as of Jul. 19, 2026. The stock has 5 warning signs investors should review. Among 689 Drug Manufacturers companies, Christina Lake Cannabis ranks better than 94.92% on this metric.
Christina Lake Cannabis (OTCPK:CLCFF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Christina Lake Cannabis's Enterprise Value for the quarter that ended in Nov. 2025 was $11.14 Mil.
Christina Lake Cannabis's EBIT for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.80 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Christina Lake Cannabis EV-to-EBIT Related Terms
Christina Lake Cannabis EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Christina Lake Cannabis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Christina Lake Cannabis EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Christina Lake Cannabis's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Christina Lake Cannabis's EV-to-EBIT falls into.
Christina Lake Cannabis's current Enterprise Value is $9.38 Mil.
Christina Lake Cannabis's EBIT for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.80 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Christina Lake Cannabis (CLCFF) has a EV-to-EBIT of 1.95 as of Jul. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Christina Lake Cannabis and its competitors. According to the industry distribution chart, Christina Lake Cannabis ranks #35 out of 689 companies in the Drug Manufacturers industry, placing it in the top 5.1%.
Is Christina Lake Cannabis' EV-to-EBIT too high?
Christina Lake Cannabis' current EV-to-EBIT is 1.95. The Drug Manufacturers industry median EV-to-EBIT is 15.73. Christina Lake Cannabis' value of 1.95 is 87.6% below this industry median. Based on the distribution chart, Christina Lake Cannabis ranks #35 out of 689 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Christina Lake Cannabis' EV-to-EBIT compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Christina Lake Cannabis ranks #35 out of 689 companies for EV-to-EBIT. This places Christina Lake Cannabis in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.73. Christina Lake Cannabis' value of 1.95 is 87.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.73, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Christina Lake Cannabis's current EV-to-EBIT of 1.95 is 87.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Christina Lake Cannabis and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Christina Lake Cannabis's current EV-to-EBIT is 1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Christina Lake Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Christina Lake Cannabis (CLCFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.04, compared to a current price of $0.02 — trading 51.8% below its estimated fair value. The current EV-to-EBIT is 1.95 and 87.6% below the Drug Manufacturers industry median of 15.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Christina Lake Cannabis (CLCFF), the current EV-to-EBIT is 1.95 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Christina Lake Cannabis Corp is a licensed producer of cannabis. The company cultivates cannabis using strains specifically developed for outdoor cultivation. It is a producer of high-quality, low-cost, sun-grown cannabis flowers, oil cannabinoids, and hemp-based extracts and derivatives, serving domestic and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCFF has been successfully added to your 
